Neurocrine Bio. (NBIX) PT Raised to $195 at Cantor Fitzgerald on Ingrezza Outlook
Tweet Send to a Friend
(Updated - March 10, 2026 9:22 AM EDT)
Cantor Fitzgerald analyst Josh Schimmer raised the price target on Neurocrine ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cantor Fitzgerald analyst Josh Schimmer raised the price target on Neurocrine ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
